Progyny (PGNY) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $27.45, -1.38% vs the prior close of $27.84.
- Volume 1.06M shares, 0.9x its 50-day average.
- New SEC filings: 144 (Oct 14, 2026).
- No new insider buys or sales reported since the prior session.
PGNY dips 1.4% to $27.45. Closed at $27.45, -1.38% vs the prior close of $27.84. Day range $27.43–$28.41, opened at $27.77.
PGNY daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — PGNY dips 1.4% to $27.45
- Closed at $27.45, -1.38% vs the prior close of $27.84. Day range $27.43–$28.41, opened at $27.77.
- Volume was 1.06M shares, 0.9x its 50-day average of 1.18M.
- Price is +3.6% vs its 50-day average ($26.51) and +13.2% vs its 200-day average ($24.26).
- 52-week range $16.10–$33.06; today's close sits at 67% of that range, 17.0% below the 52-week high.
Oct 14, 2026 — PGNY rises 1.6% to $27.84
- Closed at $27.84, +1.64% vs the prior close of $27.39. Day range $27.26–$28.06, opened at $27.26.
- Volume was 774.00K shares, 0.7x its 50-day average of 1.18M.
- Price is +4.7% vs its 50-day average ($26.59) and +14.8% vs its 200-day average ($24.25).
- 52-week range $16.10–$33.06; today's close sits at 69% of that range, 15.8% below the 52-week high.
Oct 13, 2026 — PGNY dips 2.3% to $27.39
- Closed at $27.39, -2.28% vs the prior close of $28.03. Day range $27.26–$28.82, opened at $28.22.
- Volume was 1.06M shares, 0.9x its 50-day average of 1.18M.
- Price is +2.7% vs its 50-day average ($26.66) and +13.0% vs its 200-day average ($24.24).
- 52-week range $16.10–$33.06; today's close sits at 67% of that range, 17.2% below the 52-week high.
Oct 12, 2026 — PGNY rises 0.4% to $28.03, a 1-month high, 7 up days in a row
- Closed at $28.03, +0.36% vs the prior close of $27.93. Day range $27.64–$28.17, opened at $27.88.
- Volume was 826.00K shares, 0.7x its 50-day average of 1.18M.
- Price is +4.8% vs its 50-day average ($26.75) and +15.7% vs its 200-day average ($24.23).
- 52-week range $16.10–$33.06; today's close sits at 70% of that range, 15.2% below the 52-week high.
- That makes 7 straight gains.
Oct 9, 2026 — PGNY rises 0.4% to $27.93, a 1-month high, 6 up days in a row
- Closed at $27.93, +0.36% vs the prior close of $27.83. Day range $27.64–$28.24, opened at $27.90.
- Volume was 694.50K shares, 0.6x its 50-day average of 1.18M — lighter than usual.
- Price is +4.2% vs its 50-day average ($26.81) and +15.3% vs its 200-day average ($24.22).
- 52-week range $16.10–$33.06; today's close sits at 70% of that range, 15.5% below the 52-week high.
- That makes 6 straight gains.
Oct 8, 2026 — PGNY rises 1.0% to $27.83, 5 up days in a row
- Closed at $27.83, +1.02% vs the prior close of $27.55. Day range $26.85–$28.00, opened at $27.51.
- Volume was 1.70M shares, 1.5x its 50-day average of 1.17M.
- Price is +3.5% vs its 50-day average ($26.88) and +14.9% vs its 200-day average ($24.22).
- 52-week range $16.10–$33.06; today's close sits at 69% of that range, 15.8% below the 52-week high.
- That makes 5 straight gains.
Oct 7, 2026 — PGNY jumps 6.3% to $27.55 on 2.0x normal volume
- Closed at $27.55, +6.33% vs the prior close of $25.91. Day range $25.81–$28.32, opened at $25.81.
- Volume was 2.26M shares, 2.0x its 50-day average of 1.16M — unusually heavy trading.
- Price is +2.2% vs its 50-day average ($26.95) and +13.8% vs its 200-day average ($24.21).
- 52-week range $16.10–$33.06; today's close sits at 67% of that range, 16.7% below the 52-week high.
- That makes 4 straight gains.
Oct 6, 2026 — PGNY ends flat (+0.2%) to $25.91, 3 up days in a row
- Closed at $25.91, +0.19% vs the prior close of $25.86. Day range $25.56–$26.24, opened at $25.86.
- Volume was 868.30K shares, 0.7x its 50-day average of 1.16M.
- Price is -4.1% vs its 50-day average ($27.01) and +7.0% vs its 200-day average ($24.20).
- 52-week range $16.10–$33.06; today's close sits at 58% of that range, 21.6% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — PGNY rises 2.5% to $25.86
- Closed at $25.86, +2.50% vs the prior close of $25.23. Day range $25.01–$25.92, opened at $25.25.
- Volume was 1.05M shares, 0.9x its 50-day average of 1.15M.
- Price is -4.7% vs its 50-day average ($27.13) and +6.8% vs its 200-day average ($24.20).
- 52-week range $16.10–$33.06; today's close sits at 58% of that range, 21.8% below the 52-week high.
Oct 2, 2026 — PGNY rises 1.5% to $25.23
- Closed at $25.23, +1.53% vs the prior close of $24.85. Day range $24.87–$25.45, opened at $24.96.
- Volume was 939.60K shares, 0.8x its 50-day average of 1.15M.
- Price is -7.4% vs its 50-day average ($27.24) and +4.2% vs its 200-day average ($24.20).
- 52-week range $16.10–$33.06; today's close sits at 54% of that range, 23.7% below the 52-week high.
PGNY latest news & SEC filings
Every SEC filing by or about PGNY in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 28, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Swartz Allison sold 3,903 shares at $26.10 (≈$101.87K) on Sep 23, 2026; now holds 75,816
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 23, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 21, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Clapp Geoffrey had withheld for taxes 819 shares at $27.38 (≈$22.42K) on Sep 17, 2026; now holds 59,009
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 18, 2026 · 4/A — Amended insider trade report (Form 4/A)
Amended insider trade report (Form 4/A)
- Gordon Kevin K converted options/RSUs into 22,000 shares at $13.00 (≈$286.00K) on Sep 10, 2026; now holds 28,792
- Gordon Kevin K had withheld for taxes 10,500 shares at $27.24 (≈$286.02K) on Sep 10, 2026; now holds 18,292
- Gordon Kevin K sold 11,500 shares at $27.12 (≈$311.86K) on Sep 10, 2026; now holds 6,792
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 14, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Gordon Kevin K sold 11,500 shares at $27.94 (≈$321.31K) on Sep 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 7, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $350.51M (prior year $332.87M) (+5.3% vs Jun 30, 2025)
- Net income: $28.05M (prior year $17.11M) (+63.9% vs Jun 30, 2025)
- Diluted EPS: $0.34 (prior year $0.19) (+78.9% vs Jun 30, 2025)
Aug 6, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 6, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade PGNY
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 26, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.58% (largest 6.3%).
- Liquidity: about 1.25M shares (≈$34.41M) trade per day on average.
- 52-week position: $27.45 vs a range of $16.10–$33.06 (67% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 1 open-market buys, 24 sales; latest: Allison Swartz sold 3,903 shares on Sep 23, 2026.
- Latest filings: 10-Q Aug 7, 2026; 8-K Aug 6, 2026; 8-K May 27, 2026.
- Share count: 76.73M shares outstanding (Jul 31, 2026), -10.8% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Services-Misc Health & Allied Services, NEC.
PGNY market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 27.77 | 28.41 | 27.43 | 27.45 | 1.06M |
| Oct 14, 2026 | 27.26 | 28.06 | 27.26 | 27.84 | 774.00K |
| Oct 13, 2026 | 28.22 | 28.82 | 27.26 | 27.39 | 1.06M |
| Oct 12, 2026 | 27.88 | 28.17 | 27.64 | 28.03 | 826.00K |
| Oct 9, 2026 | 27.90 | 28.24 | 27.64 | 27.93 | 694.50K |
| Oct 8, 2026 | 27.51 | 28.00 | 26.85 | 27.83 | 1.70M |
| Oct 7, 2026 | 25.81 | 28.32 | 25.81 | 27.55 | 2.26M |
| Oct 6, 2026 | 25.86 | 26.24 | 25.56 | 25.91 | 868.30K |
| Oct 5, 2026 | 25.25 | 25.92 | 25.01 | 25.86 | 1.05M |
| Oct 2, 2026 | 24.96 | 25.45 | 24.87 | 25.23 | 939.60K |
| Oct 1, 2026 | 25.11 | 25.37 | 24.79 | 24.85 | 1.59M |
| Sep 30, 2026 | 24.83 | 25.49 | 24.80 | 25.19 | 980.50K |
| Sep 29, 2026 | 25.25 | 25.34 | 24.33 | 24.79 | 1.55M |
| Sep 28, 2026 | 25.47 | 25.96 | 25.40 | 25.52 | 1.08M |
| Sep 25, 2026 | 25.88 | 26.05 | 25.39 | 25.44 | 1.11M |
| Sep 24, 2026 | 25.66 | 26.21 | 25.25 | 25.97 | 1.33M |
| Sep 23, 2026 | 26.10 | 26.42 | 25.64 | 25.83 | 1.35M |
| Sep 22, 2026 | 26.96 | 27.15 | 26.16 | 26.24 | 882.00K |
| Sep 21, 2026 | 27.22 | 27.25 | 26.67 | 26.86 | 821.00K |
| Sep 18, 2026 | 27.01 | 27.30 | 26.95 | 27.13 | 3.14M |
About Progyny
Progyny (PGNY) is listed on the Nasdaq and classified by the SEC under “Services-Misc Health & Allied Services, NEC”. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1551306.
PGNY board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Peter Anevski | CHIEF EXECUTIVE OFFICER | Sep 8, 2026 |
| Elizabeth D Bierbower | Director | May 26, 2026 |
| Lloyd H Dean | Director | May 26, 2026 |
| Kevin K Gordon | Director | Sep 18, 2026 |
| Roger C Holstein | Director | May 26, 2026 |
| Debra L Morris | Director | May 26, 2026 |
| Jeffrey G Park | Director | May 26, 2026 |
| Norman Payson | Director | May 26, 2026 |
| David J Schlanger | Executive Chairman | Jan 5, 2026 |
| Cheryl Scott | Director | Jun 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Peter Anevski | CHIEF EXECUTIVE OFFICER | Sep 8, 2026 |
| Geoffrey Clapp | Chief Product Officer | Sep 21, 2026 |
| Melissa B Cummings | Chief Operating Officer | Jul 16, 2026 |
| Mark S. Livingston | CHIEF FINANCIAL OFFICER | Sep 8, 2026 |
| David J Schlanger | Executive Chairman | Jan 5, 2026 |
| Michael E Sturmer | PRESIDENT | Jan 5, 2026 |
| Allison Swartz | EVP, GC | Sep 28, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 23, 2026 | Allison Swartz | Sale | 3,903 | $26.10 |
| Sep 10, 2026 | Kevin K Gordon | Sale | 11,500 | $27.12 |
| Sep 10, 2026 | Kevin K Gordon | Sale | 11,500 | $27.94 |
| Jul 14, 2026 | Melissa B Cummings | Sale | 2,244 | $31.60 |
| Jun 4, 2026 | Mark S. Livingston | Sale | 599 | $25.50 |
| Jun 4, 2026 | Mark S. Livingston | Sale | 1,918 | $25.50 |
| Jun 4, 2026 | Allison Swartz | Sale | 599 | $25.08 |
| Jun 3, 2026 | Allison Swartz | Sale | 1,199 | $25.02 |
| Jun 2, 2026 | Mark S. Livingston | Sale | 279 | $26.20 |
| Jun 2, 2026 | Geoffrey Clapp | Sale | 1,530 | $25.58 |
| Jun 1, 2026 | Cheryl Scott | Sale | 7,439 | $26.39 |
| May 28, 2026 | Allison Swartz | Sale | 2,398 | $25.46 |
| May 27, 2026 | Kevin K Gordon | Sale | 5,500 | $24.99 |
| May 20, 2026 | Mark S. Livingston | Sale | 8,275 | $25.50 |
| May 19, 2026 | Melissa B Cummings | Sale | 9,578 | $25.00 |
PGNY financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.29B | $58.52M | 0.65 | $210.19M |
| Dec 31, 2024 | $1.17B | $54.34M | 0.57 | $179.10M |
| Dec 31, 2023 | $1.09B | $62.04M | 0.62 | $188.81M |
| Dec 31, 2022 | $786.91M | $30.36M | 0.30 | $80.39M |
| Dec 31, 2021 | $500.62M | $65.77M | 0.66 | $26.04M |
Latest balance sheet: total assets $715.84M, total liabilities $262.58M, cash $152.63M (as of Jun 30, 2026).
PGNY earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $30.21 |
| May 7, 2026 | 8-K Item 2.02 (results) | $19.16 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $22.25 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $28.42 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $18.01 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $23.06 |
| Jul 8, 2025 | 8-K Item 2.02 (results) | $24.27 |
| May 8, 2025 | 8-K Item 2.02 (results) | $23.37 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $22.88 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $20.30 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $17.18 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Misc Health & Allied Services, NEC
Davita (DVA)Sotera Health (SHC)Fresenius Medical Care AG (FMS)agilon health (AGL)Viemed Healthcare (VMD)NewGenIvf (NIVF)Park Dental Partners (PARK)Mangoceuticals (MGRX)Cryo Cell International (CCEL)BioRestorative Therapies (BRTX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on PGNY
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.